Video & Transcript : 'pharmaceutical expansion' :

Page 69 of 391
VT

Vermont 2025-2026 Regular Session

House Caucus of the Whole - H.955 report - 2026-04-14 - 11:11AM

Vermont House Floor Meeting

Transcript Highlights:
  • you is that as a result of a lot of the health care work we did last year, specifically around pharmaceutical
CA
Transcript Highlights:
  • I'm the chief of the Pharmaceutical Policy and Programs Branch at HCAI.
Summary: The Assembly Budget Subcommittee on Health held an informational hearing on the Governor’s May Revision, focusing first on the Commission on Behavioral Health, then EMSA, and then the California Department of Public Health (CDPH). The Department of Finance said the state faces a third consecutive deficit and that the May Revision includes difficult trade-offs, including proposed eliminations or reversions of some behavioral health and public health funds. The LAO echoed concern about the structural deficit and said it was still awaiting some budget details before offering a full analysis. For the Commission on Behavioral Health, Finance proposed eliminating $20 million in Mental Health Wellness Act funds, arguing the money would help offset General Fund costs and noting future Proposition 1 innovation funding. The commission strongly opposed the cut, saying it would eliminate or delay launch-ready grants for early childhood supports, full-service partnerships, and peer respite, and would eventually end ongoing grant programming. Several advocates and commissioners testified that the funds support underserved communities and that Proposition 1 is not a substitute for the existing programs. The chair asked Finance to look for alternatives, but no vote was taken. EMSA presented mostly technical budget adjustments: increased authority for the California Poison Control System, a correction to EMSIS funding, and a reappropriation for enterprise services and data management. CDPH then reviewed a broader set of May Revision proposals, including reversions from the California Reducing Disparities Project, workforce development, STD prevention, hepatitis C prevention, hospice, and extreme heat funding, as well as a new generative AI pilot for health facility survey reporting. Members raised concerns about cuts to CRDP and gender health equity programs, especially because many grants are mid-contract and serve underserved communities; CDPH said the reversions were part of solving the deficit and that CRDP had been successful, while also clarifying that abortion.ca.gov would not be eliminated. Public comment was overwhelmingly opposed to the CRDP and related cuts, with many speakers describing the programs as life-saving and cost-effective. No formal votes or actions were taken during the hearing.
HI

Hawaii 2026 Regular Session

EDT-GVO, EDT-WLA, EDT DEFER, EDT-EDU DEFER Public Hearings 02-19-2026

Economic Development and Tourism

Transcript Highlights:
  • engaged in biomed or life sciences research, clinical trials, medical technology development, pharmaceutical
  • engaged in biomed or life sciences research, clinical trials, medical technology development, pharmaceutical
Summary: The committee first heard SB 2627, which would exempt Hawaii Tourism Authority contracts and agreements for sports projects, events, and related marketing from the state procurement code and other competitive bidding requirements. HTA, DBEDT, and the State Procurement Office testified in support or with comments, while one individual offered general support for sports tourism. Senators focused on narrowing the bill so the exemption would apply more specifically to sports-related projects and marketing, rather than broad marketing activities, and discussed whether the bill should require notice to the State Procurement Office or approval by the chief procurement officer. Procurement officials said a reporting requirement would be the most expeditious option, while still allowing post-event monitoring and public posting of exemptions. Members also discussed whether the exemption should be limited to situations involving sole-source sports entities, such as major leagues or international sports organizations, to better justify bypassing procurement rules. The committee did not take a final vote in the portion provided, but members and testifiers agreed to continue working on the language. The hearing then moved to SB 2074 relating to state facilities and naming rights for the Aloha Stadium and Hawaii Convention Center. The Stadium Authority, HTA, and DBEDT testified in support, while the Outdoor Circle and other organizations opposed the measure. Opponents argued the bill could create fiscal and legal risk, echoing concerns raised in prior legislation and by the attorney general, and warned it would mark a major shift by treating public facilities as commercial branding opportunities. Supporters said naming rights could generate significant revenue to help fund the stadium project and reduce the burden on the state and developers. Senators questioned how signage would be handled, especially whether it would be exterior-facing or limited to inward-facing signage, and the Stadium Authority said it was willing to work with the Outdoor Circle on language that would preserve community aesthetics while allowing revenue generation. A senator cited a prior study estimating naming rights could bring in about $1.5 million per year over 20 years, and asked what that revenue would buy for the public; the Stadium Authority responded that it would help advance the project toward a larger, improved stadium. No final action was taken in the excerpt provided.
NH
Transcript Highlights:
  • because it’s not me—it’s this committee, and the fact that this committee does not like their pharmaceutical
  • that this committee um does not like that this committee um does not like their<01:55:52.599><c> pharmaceutical
Summary: The committee first took up House Bill 167, a PFAS-related measure expanding the state’s restrictions to include ski wax and related fluorocarbons. The sponsor said the bill was a follow-up to last year’s PFAS law and largely targeted products already off the market, describing it as a reaffirmation of the state’s intent to keep PFAS out of water. The committee voted unanimously to recommend the bill ought to pass and then placed it on the consent calendar. Next, the committee considered House Bill 275 on health career credentialing requirements. The discussion centered on a proposal that would have required insurance companies to pay for training mandated by federal requirements. Members concluded that approach was not appropriate and voted unanimously to make the bill inexpedient to legislate, then placed it on the consent calendar. House Bill 276, dealing with on-premise beverage license requirements, was then reconsidered after an initial ITL vote. The committee adopted an amendment creating a tavern license for establishments limited to patrons over 21, with a higher fee and no food requirement, and then voted 15-0 to recommend the bill ought to pass as amended; it was also placed on the consent calendar. The committee then took up House Bill 310, which would establish a commission to study a regulatory framework for stable tokens and tokenization of real-world assets. The sponsor said the amendment added blockchain-based trusts and discussion of privacy and environmental concerns. The committee approved the amendment 16-0 and then voted 16-0 to recommend the bill ought to pass as amended, placing it on the consent calendar. House Bill 312, concerning intercollegiate student athletes’ right to earn compensation from name, image, and likeness, was retained because members said the issue was not ready and the NCAA had not resolved how to handle it. Finally, the committee began discussion of House Bill 316 on ground ambulance reimbursement, with an amendment that would replace the bill’s reimbursement provisions with a study commission; members debated how it related to another bill, HB 725, and whether the amendment would delay immediate relief for ambulance providers.
MN

Minnesota 2025-2026 Regular Session

House Health Finance and Policy Committee 3/3/25

Health Finance and Policy

Transcript Highlights:
  • promote, preserve, and protect public health and safety by fostering the safe distribution of pharmaceuticals
  • and the provision of quality pharmaceutical care to the citizens of Minnesota.
US

US Federal 2025-2026 Regular Session

US House Floor Proceedings (Wednesday, April 15, 2026)

US Federal House Floor Meeting

Transcript Highlights:
  • These are the real dollars that can be reinvested into workers, equipment, or expansion.
  • the tax on overtime is the CEO of cut the tax on overtime is the CEO of the<06:09:33.440><c> pharmaceutical
  • </c><06:09:34.160><c> companies</c><06:09:34.558><c> who</c><06:09:34.798><c> makes</c> the pharmaceutical
  • companies who makes the pharmaceutical companies who makes $12<06:09:35.280><c> million</c><06:09:35.760
Bills: HR1156 , HB6398 , HB6409 , HR965 , HR1174 , HR1176 , HCR40
TX

Texas 89th Regular

Senate Session Apr 7th, 2025

Texas Senate Floor Meeting

Bills: SJR12 , SJR81 , SCR39 , SB22 , SB32 , SB241 , SB393 , SB414 , SB458 , SB464 , SB568 , SB583 , SB609 , SB660 , SB693 , SB731 , SB732 , SB746 , SB783 , SB785 , SB897 , SB993 , SB996 , SB1008 , SB1029 , SB1035 , SB1036 , SB1120 , SB1122 , SB1147 , SB1163 , SB1188 , SB1197 , SB1209 , SB1227 , SB1245 , SB1267 , SB1307 , SB1321 , SB1332 , SB1386 , SB1394 , SB1396 , SB1470 , SB1494 , SB1537 , SB1596 , SB1598 , SB1610 , SB1664 , SB1814 , SB1822 , SB1841 , SB1948 , SB2065 , SB2155 , SB2406 , SB2407 , SJR12 , SJR36 , SJR81 , SJR50 , SJR4 , SCR22 , SCR12 , SCR39 , SB765 , SB62 , SB666 , SB888 , SB687 , SB847 , SB1248 , SB504 , SB305 , SB296 , SB284 , SB241 , SB304 , SB1023 , SB204 , SB609 , SB670 , SB850 , SB854 , SB413 , SB1346 , SB1033 , SB1220 , SB1073 , SB810 , SB1539 , SB447 , SB1119 , SB1505 , SB1215 , SB1302 , SB583 , SB673 , SB681 , SB1172 , SB955 , SB957 , SB1120 , SB541 , SB266 , SB1415 , SB53 , SB1352 , SB785 , SB1450 , SB1502 , SB1566 , SB414 , SB1062 , SB711 , SB746 , SB1404 , SB1448 , SB507 , SB1026 , SB1349 , SB1355 , SB1433 , SB1434 , SB1596 , SB1403 , SB667 , SB1059 , SB1567 , SB310 , SB311 , SB505 , SB1209 , SB1210 , SB1470 , SB264 , SB1029 , SB1358 , SB1364 , SB1569 , SB1376 , SB1228 , SB519 , SB1350 , SB462 , SB827 , SB1585 , SB1396 , SB1484 , SB1273 , SB927 , SB1227 , SB1229 , SB1353 , SB1464 , SB1709 , SB1729 , SB1733 , SB1744 , SB1772 , SB1841 , SB1147 , SB1008 , SB2016 , SB1173 , SB1163 , SB996 , SB568 , SB1370 , SB1321 , SB1101 , SB860 , SB993 , SB693 , SB1610 , SB1537 , SB1332 , SB1307 , SB963 , SB493 , SB984 , SB619 , SB1122 , SB455 , SB522 , SB1057 , SB1239 , SB1254 , SB1255 , SB1259 , SB1341 , SB1664 , SB1877 , SB464 , SB1277 , SB32 , SB732 , SB660 , SB731 , SB921 , SB268 , SB1822 , SB1188 , SB1589 , SB397 , SB1058 , SB1036 , SB1267 , SB2112 , SB1930 , SB532 , SB1035 , SB2155 , SB508 , SB292 , SB291 , SB901 , SB1333 , SB1436 , SB1494 , SB964 , SB779 , SB1378 , SB2312 , SB1719 , SB1386 , SB287 , SB2143 , SB1245 , SB261 , SB1247 , SB1948 , SB2406 , SB2407 , SB1882 , SB1197 , SB1814 , SB618 , SB38 , SB393 , SB2065 , SB1371 , SB1394 , SB1365 , SB2243 , SB2226 , SB2039 , SB1919 , SB1895 , SB1598 , SB1493 , SB1810 , SB1791 , SB1706 , SB1644 , SB1238 , SB783 , SB458 , SB22 , SB651 , SB897 , SB1809 , SB1080 , SB745 , SB826 , SB989 , SB1320 , SB1437 , SB2320 , SB2289 , SB1171 , SB664 , SB1637 , SB2064 , SB868 , SJR40 , SJR27 , SCR38 , SCR37 , SB1079 , SB1243 , SB1504 , SB1851 , SB1879 , SB2237 , SB1257 , SB2034 , SB1522 , SB883 , SB249 , SB1318 , SB1151 , SB596 , SB1191 , SB226 , SB570 , SB870 , SB991 , SB60 , SB365 , SB1067 , SB1786 , SB326 , SB1401 , SB1592 , SB1728 , SB1265 , SB586 , SB529 , SB217 , SB209 , SB1923 , SB1559 , SB1839 , SB387 , SB1874 , SB1872 , SB1873 , SB1921 , SB1883 , SB1677 , SB95 , SB1620 , SB1838 , SB2024 , SB2429 , SB1999 , SB511 , SB2309 , SB2166 , SB871 , SB510 , SB33 , SB2420 , SB1860 , SB1541 , SB1316 , SB1314 , SB1313 , SB1426 , SB1398 , SB1869 , SB1750 , SB1871 , SB36 , SB855 , SB1233 , SB760 , SB2425 , SB2037 , SB1758 , SB1759 , SB2365 , SB1924 , SB762 , SB1271 , SB1818 , SB605 , SB1405 , SB1762 , SB1968 , SB1977 , SB2077 , SB2148 , SB2321 , SB1967 , SB1662 , SB1663 , SB2124 , SB2204
Summary: The meeting primarily focused on educational reforms, particularly in special education funding. Notably, Senator Bettencourt laid out the transformative impacts of Senate Bill 568, which aims to lift a historical cap on special education funding that affected approximately 775,000 students. The discussions included plans for an intensity-based funding model that could ensure fair distribution of resources depending on individual needs, thereby enhancing educational support for diverse learning requirements. Senators acknowledged past failures in the special education framework, emphasizing the necessity of moving towards a system that is transparent and focused on delivering adequate services.
NH

New Hampshire 2025 Regular Session

House Health, Human Services and Elderly Affairs (04/23/2025)

Health, Human Services & Elderly Affairs

Transcript Highlights:
  • pharmacists must graduate from a Doctor of Pharmacy program accredited by the Accreditation Council for Pharmaceutical
  • accredited by the accreditation<02:15:11.840><c> council</c><02:15:12.159><c> for</c><02:15:12.320><c> pharmaceutical
  • </c> accreditation council for pharmaceutical accreditation council for pharmaceutical education,<02:
MN

Minnesota 2025-2026 Regular Session

Committee on Commerce and Consumer Protection - 03/05/26

Commerce and Consumer Protection

Transcript Highlights:
  • point out here that the state definition laid out for a mandated health benefit proposal is more expansive
  • benefit proposal for a mandated health benefit proposal is<00:04:06.239><c> more</c><00:04:06.480><c> expansive
  • </c><00:04:07.200><c> than</c><00:04:07.680><c> the</c><00:04:08.080><c> federal</c> is more expansive
  • than the federal is more expansive than the federal definition<00:04:09.760><c> um</c><00:04:09.920>
  • The money health plans use to make payments for health care services and pharmaceuticals comes from the
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Financial Services Jun 21st, 2026 at 12:30 pm

Joint Committee on Financial Services

Transcript Highlights:
  • The pharmaceutical companies are funding that program at Boston University, and it's biased on one profession
Summary: The Joint Committee on Financial Services held a public hearing on a wide range of bills, with testimony first focused on H. 1315/S. 824, which would require insurance coverage for pain management options during IUD insertion. Representative Sabadosa, Planned Parenthood clinicians, and policy advocates said sedation can reduce fear and trauma, improve access to effective contraception, and should be reimbursed so providers can continue offering it. A Tufts OB-GYN resident also testified that pain control should be standard care for intrauterine procedures. No votes were taken during the hearing. The committee then heard extensive testimony on firefighter health bills, especially H. 1230/S. 690 requiring insurance coverage for cancer screenings for firefighters. Professional Fire Fighters of Massachusetts leaders, a Dana-Farber oncologist, and firefighters themselves described occupational exposure to carcinogens and personal stories of late-stage cancer detection, arguing that early screening can save lives and reduce long-term costs. Representative Crichton and Representative Howitt also spoke in support, and Representative Ayers testified for H. 4012, which would require neurological disorder screenings for firefighters. Committee members expressed support and sympathy, but no action was taken. The hearing also covered H. 3946/S. 756 on hearing aid coverage, with testimony from students, adults with hearing loss, disability advocates, and HLAA representatives describing the educational, social, and financial barriers caused by lack of coverage and urging broader insurance mandates. Later, Representative Donahue and Representative Vargas testified for H. 1337 to expand insurance coverage for opioid antagonists and related medications, including naloxone dispensed at discharge. The committee additionally heard testimony on H. 1134 to improve chronic pain care coordination and non-opioid access, and H. 4162 to improve ostomy supply coverage and access to certified ostomy care, with patients and clinicians describing denials, quantity limits, and non-medical switching. The transcript ends while testimony on H. 1315/S. 824 is still ongoing; no votes or formal committee actions are recorded in the excerpt.
CA

California 2025-2026 Regular Session

Assembly Transportation Committee Jun 8th, 2026

Transcript Highlights:
  • That's not how we regulate aviation, it's not how we regulate pharmaceuticals, and it should not be how
Summary: The Assembly Transportation Committee heard an informational hearing on California’s newly finalized autonomous vehicle regulations, with DMV and CHP officials describing the updated framework and committee members pressing them on safety, enforcement, and first-responder impacts. DMV said the rules, effective April 28, 2026, expand reporting, create a phased permitting system from testing to deployment, add requirements for safety cases, remote operations, and first-responder coordination, and open a path for heavy-duty AV testing and deployment while still prohibiting oversized loads and hazardous materials. CHP said it worked with DMV on enforcement tools, first-responder interaction plans, and training local agencies on the new notice of noncompliance process. Members asked about crash data, immobilizations, freeway and construction-zone safety, weigh-station enforcement, and whether foreign licenses can qualify for remote assistants or drivers; DMV and CHP said the rules are intended to keep AVs accountable and that heavy-duty AVs will be held to the same roadway standards as human-driven commercial vehicles. A second panel focused on data collection and enforcement. Consumer attorneys argued the prior rules were too limited because DMV stopped collecting meaningful data once AVs moved from testing to deployment, making it difficult for the public and litigants to understand incidents; they supported the new regulations but urged that the collected information be made public. The industry association said California now has the nation’s most robust AV oversight, with monthly or quarterly reporting of collisions, system failures, immobilizations, harsh braking, vehicle miles traveled, and notices of noncompliance, plus broad DMV authority to restrict or suspend operations. In response to questions, the industry said it generally supports the new framework, believes the regulations are clear, and does not favor full federal preemption of state AV rules, though it wants federal standards for design, construction, and performance. A third panel addressed first-responder interaction and remote operations. The San Francisco Fire Department described repeated AV interference with emergency scenes and said AVs have generated hundreds of “sleeper calls,” where passengers fall asleep and trigger 911 responses; the department said these incidents consume significant staff time and it wants better protocols to reduce unnecessary dispatches. Waymo said it has trained thousands of public-safety personnel, maintains a 24/7 emergency line, uses geofencing/avoid-the-area messages, and can allow first responders to manually override or move vehicles when needed. Committee members asked about sleeper-call prevention, remote assistant licensing and drug testing, communication redundancies during outages, and how manual overrides work for vehicles without traditional controls; Waymo said it is collaborating with responders and that its vehicles are designed to reach a safe stop if connectivity is lost. The final panel began with testimony on heavy-duty autonomous vehicles. A transportation researcher said freight is essential to California’s economy and that heavy-duty AVs pose distinct safety risks because of their weight, stopping distance, and the potentially severe consequences of crashes or immobilizations on highways. He said the new regulations are important because they create a regulated pathway for heavy-duty AV deployment, require a safety case, set mileage thresholds, and add reporting categories that can serve as leading safety indicators. The hearing was still in progress when the transcript ended, with additional testimony expected from labor and industry witnesses on heavy-duty AV deployment.
FL

Florida 2026 4th Special Session

February 26, 2026 - 03:30 PM

Commerce Committee

Transcript Highlights:
  • Up next, we have Michael Kent Tends with Pharmaceutical Care Management Association, waiving and support
Summary: The committee first considered CS/HB 1263 on the Office of Insurance Regulation. The sponsor said the bill would strengthen OIR’s tools to oversee property insurance, including market conduct and solvency exams, claims handling oversight, mandatory discounts for certain mitigation measures, storage of mitigation inspection forms, and clearer authority over pharmacy benefit managers. An amendment narrowing fingerprinting requirements was adopted, and the bill passed favorably after supportive testimony from OIR and others. Members then heard CS/HB 527, which would require a human review before an insurance claim can be denied or reduced when artificial intelligence or automated systems are used. After an amendment removing the term “algorithm” was adopted, the bill drew opposition from several insurance industry groups, while consumer and labor witnesses supported it. The sponsor argued the measure was needed after reports of AI-driven claim denials, and the bill passed favorably. The committee also approved CS/HB 637 on farm equipment “lemon law” protections, with an amendment clarifying who qualifies as a consumer, refund rights, repair timelines, and an effective date. The committee next took up CS/HB 1007 on data centers, which would create a regulatory framework for siting and operating large data centers, limit NDAs in some circumstances, set PSC tariff requirements, and restrict certain locations near homes and schools. After an amendment narrowing the five-mile buffer to data centers over 50 megawatts and adding noise-study requirements, the bill drew mixed testimony from business, consumer, and local-government groups, with supporters emphasizing guardrails and opponents warning about competitiveness and site restrictions. The bill passed favorably despite several no votes. Later, the committee approved CS/HB 1291 on the NICA birth-related neurological injury compensation program after a strike-all amendment revised reimbursement and assessment provisions; testimony included support from NICA and concerns from the Florida Justice Association and a family affected by the program. The committee also passed CS/HB 185 on a sales tax exemption for home-hardening products, CS/HB 425 on a historic African-American cemetery preservation program, CS/CS/CS/HB 1177 on Space Florida and spaceport operations, CS/CS/CS/HB 657 on community associations and HOA/condo reforms, and CS/CS/HB 1221, the DFS agency package. The final bill discussed was CS/HB 1001, which would restrict county and municipal DEI-related actions and contracting; the sponsor explained the strike-all, and members began questioning its definitions and exceptions, but the transcript cuts off before the bill’s final disposition.
FL

Florida 2026 Regular Session

February 26, 2026 - 03:30 PM

Commerce Committee

Transcript Highlights:
  • Up next, we have Michael Kent Tends with Pharmaceutical Care Management Association, waiving in support
Summary: The committee first heard CS/HB 1263 on insurance regulation. The sponsor said the bill would strengthen the Office of Insurance Regulation’s tools to oversee property and auto insurance markets, including market conduct and solvency exams, mitigation discounts, storage of mitigation inspection forms, and clearer oversight of pharmacy benefit managers. An amendment narrowing fingerprinting requirements was adopted, and the bill passed favorably after supportive testimony from OIR and others. Members then considered CS/HB 527, which would require a qualified human review before an insurance claim can be denied or reduced when artificial intelligence is used in the process. After an amendment removing the word “algorithm” was adopted, insurers and trade groups testified in opposition, arguing current law already covers claims handling and that the bill could create duplicative work and slow innovation. Supporters, including a consumer and labor representative, said human judgment is needed to protect claimants. The bill passed favorably. The committee also approved CS/HB 637 on farm equipment “lemon law” rights, with an amendment clarifying consumer definitions, refund rights, repair-period extensions, and a July 1, 2026 effective date. CS/HB 107 on data centers also passed after an amendment narrowing the five-mile siting restriction to data centers over 50 megawatts and adding noise-study requirements; business groups supported a framework but opposed the NDA ban and siting limits, while several members raised competitiveness and local-impact concerns. Later, the committee passed CS/HB 1291 on NICA funding and solvency, CS/HB 185 on a sales tax exemption for home-hardening products, CS/HB 425 on historic African-American cemetery preservation, CS/CS/CS/HB 1177 on Space Florida and spaceport operations, CS/CS/CS/HB 657 on community associations and HOA/condo reforms, and CS/CS/HB 1221, the DFS package. The final major item discussed was CS/HB 1001 on local government DEI restrictions, which drew extensive questioning about definitions, exceptions, cultural and religious observances, advisory councils, and contracting rules; the transcript cuts off before the bill’s final disposition.
HI

Hawaii 2026 Regular Session

HHS Public Hearing 01-30-2026

Health and Human Services

Transcript Highlights:
  • So my understanding with pharmacy and pharmaceutical drugs is that isn't there like an FDA requirement
Summary: The HHS committee met in Room 224 and announced the hearing was being streamed live, with a one-minute limit on testimony. The chair explained that written testimony had already been reviewed and that speakers should either add new comments or stand on their written testimony. The committee first heard SB 2211, an emergency appropriation to the Department of Human Services. Testimony was overwhelmingly in support, including DHS, Aloha United Way, the Hawaii Food Industry Association, the Hawaii Public Health Institute, Catholic Charities, and many individuals. Supporters emphasized the importance of maintaining SNAP-related food assistance and emergency food delivery, while Catholic Charities raised a question about whether the bill’s language would also reach food banks serving food-insecure households that are not on SNAP. No opposition was heard and the bill was moved on without questions from members. The committee then heard SB 2025, which would exempt actively practicing advanced practice registered nurses from jury duty. Testimony was broadly supportive from nursing and health organizations, including the Hawaii American Nurses Association, the Hawaii affiliate of the College of Nurse Midwives, the Hawaii State Board of Nursing, and others. One witness from Kaiser Permanente requested an amendment to include physician assistants, and a committee member asked the Board of Nursing to review that request. The bill otherwise drew no opposition and no further member questions. SB 2038, relating to medication labeling, drew the most extended discussion. The measure would change labeling requirements for certain abortion medications, and testimony was split between supporters who framed it as a privacy and access issue and opponents who raised patient safety, ethics, and transparency concerns. The Department of Health supported the intent but requested an amendment to allow quicker access to private information during investigations without a subpoena. The Board of Pharmacy said it supported the written comments but noted operational challenges and possible cost impacts, while Kaiser said compliance would likely require manual workarounds and could slow pharmacy processes. The chair and members questioned whether patients could simply remove labels themselves, but witnesses said there could still be safety and access issues if the patient is not the one receiving the prescription. The committee then moved on to SB 2050, relating to chiropractic, which received support from the Hawaii Board of Chiropractic and the Hawaii State Chiropractic Association, with no substantive opposition noted. The hearing later turned to SB 201, relating to insurance, which appeared to be a new mandated-benefit measure tied to infertility/IVF coverage. The Hawaii Civil Rights Commission provided comments, while Hawaii Family Forum opposed the bill, arguing it went beyond medical infertility and raised ethical and public policy concerns. Kaiser and the Hawaii Association of Health Plans both asked for a study or audit, saying the measure could create new insurance mandates and increase costs for residents and employers. Private Work Hawaii strongly supported the bill as an equity issue. The committee noted there was no quorum for decision-making and deferred action on the measure to a later hearing, then recessed.
TX

Texas 89th Regular

89th Legislative Session Jun 1st, 2025

Texas House Floor Meeting

Transcript Highlights:
  • Agreed to revisions, move the Texas Pharmaceutical Initiative and the multi-state compact from the upcoming
Bills: HCR158 , HCR159 , HCR160 , HCR161 , HCR162 , HCR163 , HCR164 , HR174 , HR427 , HR790 , HR810 , HR857 , HR866 , HR882 , HR883 , HR962 , HR966 , HR1001 , HR1045 , HR1085 , HR1097 , HR1127 , HR1138 , HR1141 , HR1150 , HR1152 , HR1292 , HR1296 , HR1304 , HR1305 , HR1306 , HR1308 , HR1309 , HR1310 , HR1311 , HR1312 , HR1313 , HR1315 , HR1317 , HR1318 , HR1320 , HR1321 , HR1322 , HR1323 , HR1324 , HR1325 , HR1327 , HR1328 , HR1329 , HR1330 , HR1331 , HR1332 , HR1333 , HR1334 , HR1335 , HR1338 , HR1340 , HR1341 , HR1342 , HR1343 , HR1344 , HR1345 , HR1346 , HR1347 , HR1348 , HR1349 , HR1352 , HR1353 , HR1354 , HR1355 , HR1358 , HR1359 , HR1360 , HR1361 , HR1362 , HR1363 , HR1364 , HR1365 , HR1366 , HR1368 , HR1369 , HR1370 , HR1380 , HR1383 , HR1384 , HR1385 , HR1386 , HR1387 , HR1388 , HR1389 , HR1390 , HR1392 , HR1393 , HR1396 , HR1397 , HR1398 , HR1399 , HR1400 , HR1402 , HR1403 , HR1404 , HR1405 , HR1406 , HR1407 , HR1408 , HR1409 , HR1410 , HR1411 , HR1412 , HR1413 , HR1414 , HR1415 , HR1417 , HR1418 , HR1419 , HR1420 , HR1421 , HR1422 , HR1424 , HR1425 , HR1426 , HR1427 , HR1428 , HR1429 , HR1430 , HR1431 , HR1432 , HR1433 , HR1434 , HR1435 , HR1436 , HR1437 , HR1438 , HR1440 , HR1441 , HR1442 , HR1443 , HR1444 , HR1445 , HR1447 , HR1448 , HR1449 , HR1450 , HR1452 , HR1453 , HR1454 , HR1455 , HR1456 , HR1458 , HR1459 , HR1460 , HR1461 , HR1462 , HR1463 , HR1464 , HR1465 , HR1466 , HR1467 , HR1469 , HR1470 , HR1471 , HR1472 , HR1473 , HR1475 , HR1477 , HCR132 , HCR154 , HR17 , HR49 , HR170 , HR275 , HR355 , HR356 , HR364 , HR369 , HR672 , HR690 , HR755 , HR756 , HR759 , HR762 , HR763 , HR781 , HR785 , HR848 , HR1240 , HR1265 , HR1303 , HR1307 , HR1314 , HR1316 , HR1319 , HR1326 , HR1336 , HR1337 , HR1350 , HR1351 , HR1367 , HR1371 , HR1372 , HR1373 , HR1374 , HR1375 , HR1376 , HR1377 , HR1378 , HR1379 , HR1382 , HR1391 , HR1395 , HR1451 , HR1457 , HR1468 , HR1474 , HR1476 , SB1637 , SB2878 , HB2885 , HB2017 , HB5246 , SB8 , SB2308 , SB1405 , HB 119 , SB3059 , SB15 , SB568 , SB2900 , HB3642 , HB3909 , SB268 , HB493 , SB2217 , HB2516 , SB650 , HB2963 , SB1610 , HB705 , SB2972 , SB1540 , HB40 , SB2753 , SB1660 , SB2024 , HB1545 , HB46